logo
Infratil signals $1b of asset sales

Infratil signals $1b of asset sales

Investment company Infratil has signalled $1 billion of asset sales in the next two to three years as it seeks to shift capital towards higher growth investments.
Shares in the NZX-listed company were down 7% to around $10.47 in morning trading after it reported a loss of $261.3 million for the year

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New director for Wellington Airport
New director for Wellington Airport

National Business Review

time2 days ago

  • National Business Review

New director for Wellington Airport

Infratil has appointed an Australian property executive, Bob Johnston, to the board of Wellington Airport. He will replace outgoing director Elizabeth Albergoni, who has served on the board since 2023. Johnston is already on the boards of Perth Airport and Australia's largest residential property developer, ASX-listed Stockland. Wellington Airport noted in a statement that Johnston had more than 30 years of international expertise in the property sector, including investment, development, project management and construction. He is currently the chief executive of ASX-listed property group GPT, and was previously the managing director of Frasers Property Australia (formerly the listed property group Australand). He has also held senior management positions with multinational construction and real estate company Lendlease, both in Australia and overseas. Dual-listed infrastructure investor Infratil owns 66% of Wellington Airport. The rest of the shares are owned by Wellington City Council. Infratil appoints four directors to the airport board and Wellington City Council two, including Wellington Mayor Tory Whanau. The latest appointment takes effect immediately.

Pacific Edge raises $16m in share sale
Pacific Edge raises $16m in share sale

Otago Daily Times

time2 days ago

  • Otago Daily Times

Pacific Edge raises $16m in share sale

Pacific Edge has raised $16 million in new equity in a placement of new ordinary shares — $1m more than it sought — after accepting over-subscriptions. On Friday, the cancer diagnostics company announced a $20m capital raise, saying it was about ensuring it had the cash reserves to capitalise on recent clinical and commercial milestones, grow in non-Medicare channels in the United States and regain Medicare coverage of its tests. It comprised a placement of $15m of new ordinary shares offered to selected investors and an offer of $5m of new shares to retail investors, by way of a share-purchase plan. The share issue was priced at $0.10 per share. Yesterday, the company said the placement — which was well-supported by existing shareholders — was completed on Friday and was subject to shareholder approval. It was now targeting the opening of a $5m offer to eligible retail investors at the same per share offer price in July or early August, with the ability to accept oversubscriptions. In a statement to the NZX, chairman Chris Gallaher said the company was delighted with the investor support it had received. The inclusion of Cxbladder in the American Urological Association's (AUA) new microhematuria guideline in February was significant and had allowed the company to view the non-coverage determination differently. "We are leveraging the important AUA guideline to build on the commercial momentum we have already established, including our plans to regain Medicare coverage," he said. Medicare coverage of the company's tests ceased after the Local Coverage Determination (LCD) became effective on April 24. In a note on Pacific Edge's FY25 financial result also released on Friday, Forsyth Barr analysts described it as "relatively uneventful". Revenue was consistent with the firm's expectations and costs were slightly higher than expected. Despite Pacific Edge being adamant for some time it had sufficient cash resources to navigate the LCD uncertainty, the analysts were not surprised by the capital raise. It was the company's 11th equity raise since 2003 — cumulative raises totalled more than $260m — which would take its share count to more than 1billion from just under 10million in 2004. Post-raise, its cash balance would be about $38m ($22.6 million at FY25) and the analysts estimated that was 16 to 18 months of cash on hand. "While this is a supportive lifeline, even in the event of [Medicare] recoverage, we aren't convinced this is the last of PEB's raises," they said. s

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store